Governing Board

Governing Board Membership:

  • Independent chairperson: Emeritus Prof Andrew Cheetham
  • The NIF Director of Operations: Prof Graham Galloway
  • The Deputy Vice-Chancellors (Research) or their nominees of the institutions that host the various nodes. The Florey Neuroscience Institutes is represented by the Scientific Director (or nominee). The South Australian institutions are represented by the Executive Director (or nominee) of the Institute of Medical and Veterinary Science.
    • UQ Node: Mr. John Kelly (nominee for Prof Robyn Ward, DVC-R)
    • USYD Node: Prof. Laurent Rivory (PVC-Strategic Collaborations and Partnerships)
    • ANSTO: Dr. Simone Richter (Group Executive Nuclear Science & Technology, and Landmark Infrastructure at ANSTO)
    • UNSW Node: A/Prof Grainne Moran (Pro-Vice-Chancellor – Research Infrastructure)
    • WSU Node: Prof. Deborah Sweeney (PVC-R)
    • Florey Node: Dr. Henry De Aizpurua (nominee for Prof Geoff Donan, Director of The Florey)
    • UMelb Node: Prof. Trevor Kilpatrick (nominee for Prof James McCluskey, DVC-R)
    • Monash Node: Prof. Ian Smith (Vice-Provost – Research & Research Infrastructure)
    • Swinburne Node: Prof. Aleksandar Subic (DVC-R)
    • LARIF Node: Prof. Steve Wesselingh (Executive Director, SAHMRI)
    • UWA Node: Prof. Robyn Owens (DVC-R)

Governing Board Charter:

The charter of the Governing Board is to provide stakeholder representation and governance for the Facility so as to meet the aims and mission set out in the Project Plan. The Board meets quarterly.

The terms of reference of the Board are to:

  • Appoint a Director of Operations and provide overall approval of the management structure and arrangements.
  • Ensure that the Facility is established, enhanced and operated in accordance with this Project Plan, and oversee the development of the Interim Implementation Plan and the Annual Business Plans including the approval of annual budgets.
  • Undertake necessary further consultation with the participating organisations, potential end-users, key interest groups, government bodies, related Australian and overseas facilities and other international and local interests to ensure comprehensive and broad-based input into the strategic planning process. · Identify the main risks involved with the Facility and develop options for managing those risks within an acceptable level.
  • Approve an evaluation strategy for the Facility, including specific milestones and performance indicators covering quantitative measures of utilisation and benefits realised.